Bayer has agreed to pay up to $2 billion as part of a settlement agreement for current and future Roundup cases that claim the herbicide causes cancer.
The company released its agreement with plaintiffs’ class counsel Wednesday which is being filed in a U.S. District Court in California that is overseeing the multi-district litigation.
As part of the plan, Bayer will establish a fund to compensate qualified claimants during a four-year program, create an advisory science panel whose findings could be used in future litigation, and a notice program.
Bayer is also requesting EPA allow a link to glyphosate research studies on labels to provide customers with greater transparency.
